Atrial Fibrillation (AF) is a major global public health challenge. The prevalence of AF has been projected to increase to 15.9 million by the year 2050, with more than half of these patients aged 80 years or older, leading to substantial public health and economic burden.
1, 2 AF increases the risk of mortality and morbidity due to stroke, congestive heart failure and impaired quality of life explaining its enormous socioeconomic implications. 3 The economic burden associated with AF is growing considerably and is driven primarily by the rising cost of hospitalizations. 4 The total cost of non-valvular AF care was estimated to be $6.7 billion per year in 2005 in United States and three-quarters of this cost is related to inpatient care. 4 Therefore, a meticulous understanding of the trends in AF related hospitalizations is critical for appropriate health care planning and reducing demands on the health care system. Further, a stratified national level study is likely to identify peculiar patterns across subpopulations and geographic regions, which may help in recognition of specific locations or vulnerable groups for targeted health care interventions.
There is paucity of data on AF hospitalization trends on a national scale. The present study was therefore, designed to perform a contemporary evaluation of the burden of AF related hospitalizations. The aims of the study were to determine temporal trends of AF hospitalizations and to assess the effect of comorbid diagnoses and demographics on in-hospital mortality, length of stay and total cost of care during the hospitalization.
Methods

Data Source
The Nationwide Inpatient Sample (NIS), created by Agency for Healthcare Research and Quality (AHRQ), is the largest all-payer inpatient database in the United States. 5 It contains all discharge data from over 1,200 hospitals located across 45 States. The NIS is available yearly, beginning educing demands on the health care system. Further, a stratified national level s stu t tudy dy d i i is s s li li like ke kely ly ly t to dentify peculiar patterns across subpopulations and geographic regions, which may help in e eco co ogn gn gnit it itio io ion n n of of o spe pe pec ci cific locations or vulnerable gr gr rou ou o p ps for targeted d d hea alt lt lth h h ca c re interventions.
discharge date, in-hospital mortality status. We further excluded all entries with same admission and discharge date (length of stay is 0) as such events might not have truly represented hospital stays for an acute condition. Similar methodology has been utilized in prior studies. 10 Disposition to another facility include transfer to skilled nursing facility (SNF), intermediate care facility
(ICF), and nursing homes (NH).
Co-morbidities associated with AF hospitalization were identified by AHRQ comorbidity measures. AHRQ co-morbidity measures identify different co-morbidities by using ICD-9-CM diagnoses and the Diagnosis Related Group (DRG) in effect on the discharge date. 11 These comorbidities are not directly related to the principal diagnosis, or the main reason for admission, and are likely to have originated prior to the hospital stay.
In order to calculate estimated cost of hospitalizations, the NIS data were merged with cost-to-charge ratios available from the Healthcare Cost and Utilization Project. We estimated the cost of each inpatient stay by multiplying the total hospital charge with cost-to-charge ratio.
Adjusted cost for each year was calculated in terms of the 2010 cost after adjusting for inflation according to the latest consumer price index (CPI) data released by US government on January 16, 2013.
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Statistical Analysis
Stata IC 11.0 (Stata-Corp, College Station, TX) and SAS 9.0 (SAS Institute Inc, Cary, North Carolina) was utilized for the analyses, which accounted for the complex survey design and clustering. Since NIS represents a 20% stratified random sample of US hospitals, analyses were performed using hospital-level discharge weights provided by the NIS, to obtain national estimates of AF hospitalizations. 5 AF hospitalizations per million US population were calculated by dividing the number of AF hospitalizations available in the NIS dataset, in a given year and are likely to have originated prior to the hospital stay. d
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Results
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A A A to o ota t l of 3,960 60 0,0 ,0 , 1 1 11 h h hos os spi pi pita ta tali li liz za zati tion on ons s s f fo or r AF F a as s pr rim im mary y y d di disc sc ch ha harg rg ge di diag agno no nosi is, s, s, w w wer ere e e re e epo po ort ted ed ed i i in n t the Table   2 ). The AF hospitalization rate was higher in female gender and white race throughout the study period. However, the relative rates of increment in AF hospitalizations over the year were higher in males compared to females (16.9% vs. 12.1%, p<0.001), and in non-whites compared to whites (35.1% vs. 25.3%, p<0.001). The mean age of the patients hospitalized with principal diagnosis of AF was 70 years. Mean age for men was 66 years, and mean age for women was 74
years. In sensitivity analysis, we found that female to male ratio is different in age>65 and <65
years. In >65 years age group, female to male ratio is 61% vs. 39% while in less than 65 years age group, the ratio is 34% vs. 66% (Figure 1 ).
In-Hospital Mortality
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Length of stay, Cost and Disposition
The median LOS was 3 days with interquartile range 2-5 days. During the study period, there was no statistically significant change in mean/median LOS. 
Table 4).
For disposition status analysis, we excluded the patients who were admitted from any other facility. The percentage of patients discharged home decreased over the last decade from 80.1% in 2000 to 70.2% in 2010. There was a corresponding increase in discharges to another facility (8.1% in 2000 to 11.5% in 2010) and need for home health care (6.7% to 13.1%). This has been shown in Figure 3 . Approximately one fourth of the patients (25.8%) were discharged to long-term care institution if AF hospitalization was complicated by acute ischemic stroke.
Length of stay and cost of AF hospitalizations increased proportionately with increase in CHADS2 score (p-value<0.01) as shown in 
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Discussion
This study reports contemporary data of AF hospitalizations over an 11-year period in United
States. The main findings of our analysis of the largest database available are: 1) there was a significant increase in AF hospitalizations over the study period; 2) most admissions occurred in patients >=65 years of age and patients older than 80 years exhibited an exponential increase in admissions and greater in-hospital mortality compared to other age groups; 3) mortality associated with AF hospitalizations decreased significantly except in patients with heart failure, who exhibited an increase in mortality; 4) the LOS remained unchanged however cost of care increased significantly over this time period, after adjusting for inflation; and 5) there was an increasing trend of disposition of patients to another facility and need for home health care.
Our contemporary findings of increasing AF hospitalization rates are in agreement with other national and international reports. [17] [18] [19] The rise in AF admission is likely due to ageing of the general population and increasing prevalence of risk factors like hypertension, obesity, sleep apnea, and diabetes. Upon further evaluation of the age differences between these hospitalizations, we found that more than two third of the patients were 65 years of age which is consistent with another national study. ; which in turn will lead to an enormous increased burden on the public health system and associated cost of care. 20 In addition, we found that the mortality in this age group was considerably higher than in the rest of the population. The increasing number of ncreasing trend of disposition of patients to another facility and need for home he he heal al lth th h c c car ar are. e e.
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Overall women had more AF related hospitalizations than men; however, after adjusting for age, young men (<65 years old) had more AF hospitalizations than young women and elderly women (>=65 years or older) had more AF related hospitalizations than elderly men. This sex specific pattern of an increase in the incidence of AF admissions with age in men and women and reversal in the sex ratio after age 65 years is very similar to that reported in previous crosssectional studies. 19, 21, 22 An encouraging finding of our study is the fact that mortality associated with AF hospitalizations has decreased in the general population. However, AF patients with concomitant heart failure may exhibit a different clinical course than the rest of AF patients. Our findings of increased in-hospital mortality in patients with AF and heart failure highlights the notion that these patients carry much worse prognosis and preventive measures should be instituted early on to reduce the number of hospitalizations. It is still not clear whether this subgroup would derive benefit from aggressive rate control or early rhythm control. 23, 24 However, results from prospective studies 25 and a meta-analysis 26 suggest that when these patients undergo catheter ablation for AF, they have an objective improvement in functional class and systolic function.
The mean length of hospital stay remained unchanged over the time period 2000-2010;
however, the total cost of care increased tremendously over this time frame. Increasing number of hospitalizations, ageing population, patient complexity and increasing disposition trend to another facility, are some of the drivers of increasing cost. This represents a staggering economic burden on the healthcare system and serves as an unequivocal reminder that hospitalizations represent the largest part of the total cost for AF treatment. Medicare was consistently the major hospitalizations has decreased in the general population. However, AF patients w w wit ith h h co o onc c ncom om omit itan a t heart failure may exhibit a different clinical course than the rest of AF patients. Our findings of n ncr cr rea ea eas se sed d d in in in-h -h -hos spi pi pit ta tal mortality in patients with A A AF F a and heart failur ur re hi high gh ghl lights the notion that h h hes s se e patients c ca ar rry y y m muc uc ch h h wo wo wors rs rse e pr pr pro og ogn no nos sis a a and d d pr rev ev ven nt ti tiv ve ve m m me ea easu su ure es s sh sh shou u uld ld b b be e e in inst st stit it tut ut u ed ed e e e ear arly ly ly on o o r r red ed educ uc u e e th th he e e nu numb mb mber er o of f f ho hospi pi pita ta ali li liza za zat ti tion on ns. s. I I It t t i i is s s sti ti t ll ll l n n not o c cle le ear ar ar w w whe he h t th ther er er t thi hi is su subg bg bgro ro roup up up w w wou u uld d d d der er riv v ve e r r benefit from m a a agg gg ggre re ess ss ssiv iv ve e e ra ate te te c c cont nt ntro ro r l l l or or e e ear ar arly ly y r r rhy hy hyth th hm m m co c nt nt ntro ro rol. l. . 23 Nearly 38% of the hospitalizations occurred in Southern region of United States, which also coincides with the "stroke belt". The southeastern region of the United States is well known for excess incidence of stroke and its risk factors such as hypertension, diabetes and heart failure when compared to the rest of the country.
30, 31
Limitations
Although administrative databases are increasingly used for clinical research, such studies are potentially susceptible to errors arising from coding inaccuracies. AF diagnosis and presence of comorbidities were based on the presence of administrative codes; however, administrative codes have been shown to be highly specific for cardiovascular diagnoses and risk factors. 32 (ICD-9-CM) code 427.31 has been validated for atrial fibrillation in the administrative database in prior studies and ICD coding for atrial fibrillation has not change over the study period. 9 We were unable to identify new onset AF and define time duration, and type (paroxysmal vs. persistent) of AF. If AF accompany with other "serious" conditions -like heart failure or stroke, then these conditions often end up as the primary diagnosis. This could underestimate AF hospitalization frequency and its sequele. The NIS considers each hospitalization as separate entry so it is not possible to separate index cases from readmissions. This could result in an overestimation of the number of admissions. Our study focused on AF hospitalizations and did not include any data when compared to the rest of the country.
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Limitations
Al Alth th hou ou ugh gh gh a a adm dm dmin nis is ist tr trat a ive databases are increasing ng gly ly used for clinic ic cal a r res es se ea earch, such studies are pote e en ntially susc sce e ept t tibl bl le e e to to o e e err rr rror or ors s ar ar ris is isin ing g g f f from m m c c coding ng ng in na nac cc ccu ur ra ac cie ies s. A AF F di d d a ag agno no nos si sis s an an nd d d pr pres ese en enc ce e o o of co omo mo morb rb rbid idit it tie ie ies s we we ere e e b ba a ase ed ed o on n th th he e e pr pr pre es esen en nce ce ce o o of f f ad ad adm mi min ni ist tr ra r ti ti tive ve ve c c cod od o e e es; ; ho ho h w we weve ver, r, r a a adm dm dmin in ini i istr r rat ativ iv i e e co code d have been sh how ow own n to to to b be e e hi h h gh gh ghly ly ly s spe pe peci ci ifi fi f c fo fo f r r r ca ca card rd rdio io i va va vasc sc cul ular ar ar d d dia ia iagn gn gnos os o es s s a a and nd nd r r ris is isk k k fa fa fact ct ctor or ors. s. s 32 32 32 (ICD-9-pertaining to AF care in outpatient setting or emergency departments; as such it may underestimate the overall AF incidence rates. The nature of the data allowed us to only examine in-hospital mortality; hence the study did not have any long term follow-up outcomes. In spite of these limitations, the present study has important strengths including a "real-world" large sample size and the absence of selection bias associated with clinical trials.
In conclusion, we report contemporary evidence suggesting persistent increase in AF hospitalizations with an associated increase in hospitalization costs. Prevention of AF hospitalizations and an effective outpatient management should be pursued to reduce burden on the health care system. 
